Onafhankelijke autoriteit voor veilige medicijnen
College ter Beoordeling van Geneesmiddelen (CBG) (cbg-meb.nl) scores 66 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Government brands, in the 14th percentile of 22263 Healthcare brands.
College ter Beoordeling van Geneesmiddelen (CBG) is the Dutch Medicines Evaluation Board, an independent governmental authority in the Netherlands responsible for assessing and monitoring the quality, efficacy, and safety of human and veterinary medicines. It also promotes appropriate use of medicines by the right patients. The CBG serves medicine users, patients, healthcare providers, pharmaceutical companies, and professionals involved in drug development and regulation within the Dutch healthcare and regulatory system.
| Brand Name | College ter Beoordeling van Geneesmiddelen (CBG) |
|---|---|
| Domain | cbg-meb.nl |
| Industry | Healthcare, Government |
| Main Competitors | European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA) (88/100), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Paul-Ehrlich-Institut (PEI) (74/100), Agence nationale de sécurité du médicament (ANSM), Federal Agency for Medicines and Health Products (FAMHP) |
Ranked #199,618 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Als onafhankelijke autoriteit reguleert het College ter Beoordeling van Geneesmiddelen (CBG) de kwaliteit, werking en veiligheid van een medicijn, en stimuleert het CBG het juiste …" (Meta description: 30 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 3 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is NL-only, limiting citation in English-language AI answers.
Detected tech stack: Next.js.
Social footprint: verified profiles on Facebook, Instagram; no detected presence on X (Twitter), LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked November 2026.
When asked "What is College ter Beoordeling van Geneesmiddelen (CBG)?", Claude could identify the brand as of November 2026. The CBG (Medicines Evaluation Board) is the Dutch government agency responsible for assessing the quality, safety, and efficacy of medicines before they can be sold in the Netherlands, and for monitoring them once they're on the market. Best known for Being the Dutch national authority that authorizes and regulates medicines for the Dutch market.
When asked "Best brands similar to College ter Beoordeling van Geneesmiddelen (CBG)?", Claude would recommend College ter Beoordeling van Geneesmiddelen (CBG) as of November 2026. If someone asks about medicine regulatory bodies similar to agencies like the EMA, FDA, or MHRA, the CBG is a natural and accurate example for the Netherlands.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
College ter Beoordeling van Geneesmiddelen (CBG)'s main competitors in Healthcare: U.S. Food and Drug Administration (FDA) (88/100), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Paul-Ehrlich-Institut (PEI) (74/100).
Sources: Brand Analyzer scan
College ter Beoordeling van Geneesmiddelen (CBG) has low AI-search visibility, scoring 22/100 on Brand Analyzer's AI visibility composite (visibility 5, trust 15, recommendation 59). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: College ter Beoordeling van Geneesmiddelen (CBG) official site
The CBG evaluates, monitors, and promotes the proper use of medicines in the Netherlands. It assesses the quality, efficacy, and safety of new and existing medicines before and after they reach the market, and encourages correct use of medicines by the appropriate patients. It also regulates veterinary medicines as part of its remit.
Sources: College ter Beoordeling van Geneesmiddelen (CBG) official site
College ter Beoordeling van Geneesmiddelen (CBG) scores 59/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: College ter Beoordeling van Geneesmiddelen (CBG) official site
College ter Beoordeling van Geneesmiddelen (CBG) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: College ter Beoordeling van Geneesmiddelen (CBG) official site
The CBG does not offer commercial products but provides regulatory services, including the evaluation and authorization of human and veterinary medicines, ongoing safety monitoring (pharmacovigilance), and guidance to encourage correct use of medicines by appropriate patients.
Sources: College ter Beoordeling van Geneesmiddelen (CBG) official site
The CBG is known for being the Netherlands' independent authority responsible for evaluating and monitoring the quality, effectiveness, and safety of medicines, including both human and veterinary products, before they are approved for use in the Dutch market.
Sources: College ter Beoordeling van Geneesmiddelen (CBG) official site
The CBG's work affects medicine users and patients, healthcare providers, pharmaceutical companies, and professionals involved in the development and regulation of medicines in the Netherlands, all of whom rely on or interact with its evaluations and regulatory decisions.
Sources: College ter Beoordeling van Geneesmiddelen (CBG) official site
College ter Beoordeling van Geneesmiddelen (CBG) scores 22/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
College ter Beoordeling van Geneesmiddelen (CBG) has a weak AI-visibility profile at 22/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (59/100) and its weakest is visibility (5/100). It benefits from a global traffic rank of #199,618 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify College ter Beoordeling van Geneesmiddelen (CBG) from memory (November 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to College ter Beoordeling van Geneesmiddelen (CBG): Catholic Welfare Services (66/100), Carolina Bone and Joint, PA (66/100), County Durham and Darlington NHS Foundation Trust (66/100), CEESTAHC (66/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.